Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Conn

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Neuroscience|March 31, 2010
Selective potentiation of the metabotropic glutamate receptor subtype 2 blocks phencyclidine-induced hyperlocomotion and brain activationE A Hackler, N E Byun, C K Jones, et al.
Annals of Neurology|January 13, 2000
Up-regulation of the metabotropic glutamate receptor mGluR4 in hippocampal neurons with reduced seizure vulnerabilityA A Lie, A Becker, K Behle, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2012
Synthesis and biological characterization of a series of novel diaryl amide M₁ antagonistsMichael S Poslusney, Christian Sevel, Thomas J Utley, et al.
Neuropharmacology|May 27, 2014
Head-to head comparison of mGlu1 and mGlu5 receptor activation in chronic treatment of absence epilepsy in WAG/Rij ratsV D'Amore, I Santolini, R Celli, et al.
Neuropharmacology|June 19, 2012
Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij ratsV D'Amore, I Santolini, C M van Rijn, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 26, 2015
Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse ModelA Ghoshal, J M Rook, J W Dickerson, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 23, 2013
N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancementK J Gregory, E J Herman, A J Ramsey, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Neuroscience|March 31, 2010
Selective potentiation of the metabotropic glutamate receptor subtype 2 blocks phencyclidine-induced hyperlocomotion and brain activationE A Hackler, N E Byun, C K Jones, et al.
Annals of Neurology|January 13, 2000
Up-regulation of the metabotropic glutamate receptor mGluR4 in hippocampal neurons with reduced seizure vulnerabilityA A Lie, A Becker, K Behle, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2012
Synthesis and biological characterization of a series of novel diaryl amide M₁ antagonistsMichael S Poslusney, Christian Sevel, Thomas J Utley, et al.
Neuropharmacology|May 27, 2014
Head-to head comparison of mGlu1 and mGlu5 receptor activation in chronic treatment of absence epilepsy in WAG/Rij ratsV D'Amore, I Santolini, R Celli, et al.
Neuropharmacology|June 19, 2012
Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij ratsV D'Amore, I Santolini, C M van Rijn, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 26, 2015
Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse ModelA Ghoshal, J M Rook, J W Dickerson, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 23, 2013
N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancementK J Gregory, E J Herman, A J Ramsey, et al.
Pageof 9